Diagnostic kit for Nasopharyngeal Carcinoma

Tarcine¡¯s second diagnostic product is an early detection of nasopharyngeal carcinoma (NPC). Most NPC cases occur in Southern China and Southeast Asia, with an exceptionally high incidence of 30-50 cases per

100,000 persons. Several etiologic factors associated with NPC have been recognized. We have discovered an accurate, inexpensive, and non-invasive diagnostic kit to detect early stage of NPC by identifying TARc gene which is expressed only in NPC patients. This immunology-based diagnostic kit is a robust and easy-to-use tool, that is capable of running on manual mode

or automated platform to provide consistent and repeatable results and can become a standard unit of measurement for health-risk monitoring.
Copyright (c) 2007 Tarcine All rights reserved.¡¡About Us£üContact Us£üSitemap¡¡